Patent · US Active

Peptide reagents and methods for detection of colon dysplasia

US8901276B2 · kind B2 · utility

2Cited by

2References

24Claims

0Family size

Assignee

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · US

Inventors

Thomas D. Wang · Lexington, US
Sharon Miller · Ann Arbor, US
Bishnu P. Joshi · Lexington, US

Key dates

Filing date	Dec 19, 2011
Grant date	Dec 2, 2014
Priority date	—
Expiry date	Dec 19, 2031

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/52
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to peptide reagents, methods for detecting colon pre-cancer (dysplasia with non-polypoid or polypoid morphology) or cancer using the peptide reagents, and methods for targeting pre-cancerous or cancerous colon cells using the peptide reagents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.